Pain Relief in Laparoscopic Surgery
1 other identifier
interventional
74
1 country
1
Brief Summary
Pain relief after laparoscopic surgery with the use of an altered gas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2019
CompletedFirst Posted
Study publicly available on registry
March 8, 2019
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2022
CompletedMarch 14, 2022
March 1, 2022
2.9 years
February 28, 2019
March 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of post-operative pain with an 11-point numerical rating score (NRS)
Assessement of pain after laparoscopic surgery with the use of the altered gas compared to standard gas with NRS, where 0 means no pain and 10 means worst imaginable pain
4 hours after laparoscopic surgery
Secondary Outcomes (9)
Assessment of post-operative pain (NRS)
8 hours, 24 hours and 7 days after laparoscopic surgery
Nausea
4 hours, 8 hours, 24 hours and 7 days after laparoscopic surgery
Post-operative use of piritramide (Dipidolor®)
Up to 24 hours after laparoscopic surgery
Assessment of degree of a possible inflammatory reaction
Through study completion, up to 7 days after laparoscopic surgery
Assessment of degree of a possible inflammatory reaction
Through study completion, up to 7 days after laparoscopic surgery
- +4 more secondary outcomes
Study Arms (2)
Altered gas (86% CO2, 10% N2O, 4% O2)
EXPERIMENTALSurgery with the use of the altered insufflation gas (86% CO2, 10% N2O, 4% O2)
Standard gas (100% CO2)
ACTIVE COMPARATORSurgery with the use of the standardized gas (100% CO2)
Interventions
Assessment of pain degree after laparoscopic surgery with the altered gas (86% CO2, 10% N2O, 4% O2)
Assessement of pain degree after laparoscopic surgery with the standardized gas (100% CO2)
Eligibility Criteria
You may qualify if:
- Woman ≥ 18 years old
- undergoing laparoscopic surgery for endometriosis, uterine myoma's, hysterectomy or colpopexy.
You may not qualify if:
- Women \< 18 years old
- Males
- Pregnancy
- Conditions associated with chronic pain, such as peripheral neuropathy, pathology of the vertebral column and osteo-articular disease.
- Conditions causing acute pain e.g. abdominal trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Jessa Hospital
Hasselt, Limburg, 3500, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Björn Stessel, MD, PhD
Jessa Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Anesthesiologist, MD, PhD
Study Record Dates
First Submitted
February 28, 2019
First Posted
March 8, 2019
Study Start
April 1, 2019
Primary Completion
February 17, 2022
Study Completion
February 17, 2022
Last Updated
March 14, 2022
Record last verified: 2022-03